MATERIAL EVENT4574.TTSE

Taiko Pharmaceutical: change in parent company or specified subsidiary

Summary

TAIKO PHARMACEUTICAL CO., LTD. filed an extraordinary report via EDINET on 2025-03-28 15:36 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100VHLN ↗ · PDL1.0 · Not investment advice